CARL ZEISS MEDITEC AG DGAP-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Quarter Results Carl Zeiss Meditec AG achieves increase in profit in first quarter 2020/21 19-Jan-2021 / 09:54 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. =---------------------------------------------------------------------------------------------------------------------- Carl Zeiss Meditec AG achieves increase in profit in first quarter 2020/21 Jena, January 19, 2021 Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of EUR 368.9 million in the first quarter of fiscal year 2020/21 (previous year: EUR 369.7 million). This corresponds to a revenue development of -0.2% vs. the past year (after adjustment for currency effects^[1]: +2.6%). Earnings before interest and taxes (EBIT)^[2] amounted to EUR 73.4 million in the first quarter of fiscal year 2020/21 (previous year: EUR 56.8 million). EBIT margin (EBIT / revenue) was 19.9% (previous year 15.4%). EBIT development benefitted in part from lower sales and marketing expenses compared to the previous year's period. In addition, EBIT includes a one-time gain from the sale of a property in the amount of around EUR 2.4 million in the current period. Earnings per share (EPS)^[3] amounted to EUR 0.52 (previous year: EUR 0.43). Full results for the first quarter 2020/21 will be published on February 8, 2021. During the further course of fiscal year 2020/21, the company expects the recovery in revenue and EBIT to continue compared to the previous year, which had seen a marked impact from the COVID-19 pandemic.
Contact for investors and press Sebastian Frericks Head of Investor Relations Carl Zeiss Meditec AG Tel.: +49 3641 220-116 E-Mail: investors.meditec@zeiss.com
^[1] Currency-adjusted revenue growth is determined by weighing sales in the comparative period with current instead of actual historical exchange rates. ^[2] Earnings before interest and taxes (also operating profit, EBIT) refers to a key earnings figure within the Carl Zeiss Meditec Group and is calculated in accordance with IFRS standards (see Annual Report 2019/20, p. 78 for reconciliation). ^[3] Earnings per share (also EPS) refers to a key earnings figure within the Carl Zeiss Meditec Group and is calculated according to IFRS standards (see Annual Report 2019/20, p. 78 for reconciliation). -----------------------------------------------------------------------------------------------------------------------
19-Jan-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de -----------------------------------------------------------------------------------------------------------------------
Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena, Germany
Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail: investors.meditec@zeiss.com
Internet: www.zeiss.de/meditec-ag/ir
ISIN: DE0005313704
WKN: 531370
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf,
Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1161506
End of Announcement DGAP News Service
=------------ 1161506 19-Jan-2021 CET/CEST
(END) Dow Jones Newswires
January 19, 2021 03:56 ET (08:56 GMT)
